Kulpeng, Wantanee <br/><br/>
Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?  [electronic resource] 

 -  Vaccine  Jun 2013 
 - 2839-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2013.03.047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cost-Benefit Analysis<br/>Humans<br/>Immunization Schedule<br/>Incidence<br/>Male<br/>Monte Carlo Method<br/>Pneumococcal Infections--economics<br/>Pneumococcal Vaccines--economics<br/>Pneumonia, Pneumococcal--economics<br/>Quality-Adjusted Life Years<br/>Thailand--epidemiology<br/>Vaccination<br/>Vaccines, Conjugate--economics